Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

Thumbnail for Real-World Impact of Atrial Fibrillation on Cardiovascular Outcomes and Healthcare Resource Utilization in Patients With Chronic Lymphocytic Leukemia

CLL - 169

Real-World Impact of Atrial Fibrillation on Cardiovascular Outcomes and Healthcare Resource Utilization in Patients With Chronic Lymphocytic Leukemia

G Rhys Williams

Poster Presenter: G Rhys Williams

Thumbnail for Real-World Comparison of Bleeding Outcomes Between Acalabrutinib and Zanubrutinib in Anticoagulated CLL Patients: A 6-Month and 1-Year Propensity-Matched Analysis Using the TriNetX Global Network

CLL - 1695

Real-World Comparison of Bleeding Outcomes Between Acalabrutinib and Zanubrutinib in Anticoagulated CLL Patients: A 6-Month and 1-Year Propensity-Matched Analysis Using the TriNetX Global Network

Ansy Patel

Poster Presenter: Ansy Patel

Previous 1...50 51 52 53 54 55 56...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Efficacy and Safety of Fixed-Duration Venetoclax-Based Therapy in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis

CLL - 1709

Efficacy and Safety of Fixed-Duration Venetoclax-Based Therapy in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis

anusree haridas

Poster Presenter: anusree haridas

Thumbnail for Global Macroeconomic Burden of Leukemia Attributable to Tobacco: A Value-of-Lost-Welfare Analysis Across 184 Countries

CLL - 1757

Global Macroeconomic Burden of Leukemia Attributable to Tobacco: A Value-of-Lost-Welfare Analysis Across 184 Countries

Kashish Magnani

Poster Presenter: Kashish Magnani

Thumbnail for Real-World Pharmacovigilance Assessment of Hematologic Safety Signals Among Bruton Tyrosine Kinase Inhibitors, Including Pirtobrutinib: Insights From the Food and Drug Administration Adverse Event Reporting System

CLL - 179

Real-World Pharmacovigilance Assessment of Hematologic Safety Signals Among Bruton Tyrosine Kinase Inhibitors, Including Pirtobrutinib: Insights From the Food and Drug Administration Adverse Event Reporting System

Klesta Cocoli

Poster Presenter: Klesta Cocoli

Thumbnail for Characterizing Patient Self-Reported Adherence to BTKis and Symptoms in CLL/SLL Using an Electronic Patient-Reported Outcomes (ePRO) Platform

CLL - 180

Characterizing Patient Self-Reported Adherence to BTKis and Symptoms in CLL/SLL Using an Electronic Patient-Reported Outcomes (ePRO) Platform

Lee Ding

Poster Presenter: Lee Ding

Thumbnail for Cardiovascular Cause-of-Death Trends in Chronic Lymphocytic Leukemia in the BTK Inhibitor Era: A Population-Based Competing Risk Analysis (SEER 2005-2022)

CLL - 183

Cardiovascular Cause-of-Death Trends in Chronic Lymphocytic Leukemia in the BTK Inhibitor Era: A Population-Based Competing Risk Analysis (SEER 2005-2022)

Yasir Aziz

Poster Presenter: Yasir Aziz

Thumbnail for When Symptoms Speak Louder Than Disease: Discordance Between Patient-Reported Symptoms and Objective Progression in Relapsed CLL

CLL - 192

When Symptoms Speak Louder Than Disease: Discordance Between Patient-Reported Symptoms and Objective Progression in Relapsed CLL

Ahmed Elazab

Poster Presenter: Ahmed Elazab

$Thumbnail for Treatment Landscape of Relapsed/Refractory CLL in Low-Resource Countries$

CLL - 239

Treatment Landscape of Relapsed/Refractory CLL in Low-Resource Countries

Muhammad Usman

Poster Presenter: Muhammad Usman

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors